These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
553 related articles for article (PubMed ID: 19570025)
21. [Pathogenesis of Parkinson's disease through LRRK2 mutation]. Ohta E; Obata F Seikagaku; 2014 Feb; 86(1):92-7. PubMed ID: 24693706 [No Abstract] [Full Text] [Related]
22. LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesis. Esteves AR; Swerdlow RH; Cardoso SM Exp Neurol; 2014 Nov; 261():206-16. PubMed ID: 24907399 [TBL] [Abstract][Full Text] [Related]
23. The R1441C mutation of LRRK2 disrupts GTP hydrolysis. Lewis PA; Greggio E; Beilina A; Jain S; Baker A; Cookson MR Biochem Biophys Res Commun; 2007 Jun; 357(3):668-71. PubMed ID: 17442267 [TBL] [Abstract][Full Text] [Related]
24. Leucine-rich repeat kinase 2 (LRRK2) cellular biology: a review of recent advances in identifying physiological substrates and cellular functions. Drolet RE; Sanders JM; Kern JT J Neurogenet; 2011 Dec; 25(4):140-51. PubMed ID: 22077787 [TBL] [Abstract][Full Text] [Related]
25. The small GTPase activity of the ROC domain from LRRK2, a Parkinson's disease related protein. Fu QS; Song AX; Li SX; Hu HY Protein Pept Lett; 2009; 16(12):1442-6. PubMed ID: 20001906 [TBL] [Abstract][Full Text] [Related]
27. Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease. Tsika E; Nguyen AP; Dusonchet J; Colin P; Schneider BL; Moore DJ Neurobiol Dis; 2015 May; 77():49-61. PubMed ID: 25731749 [TBL] [Abstract][Full Text] [Related]
34. LRRK2 Parkinson's disease: from animal models to cellular mechanisms. Lin CH; Tsai PI; Wu RM; Chien CT Rev Neurosci; 2011; 22(4):411-8. PubMed ID: 21679126 [TBL] [Abstract][Full Text] [Related]
35. Phosphorylation-dependent 14-3-3 binding to LRRK2 is impaired by common mutations of familial Parkinson's disease. Li X; Wang QJ; Pan N; Lee S; Zhao Y; Chait BT; Yue Z PLoS One; 2011 Mar; 6(3):e17153. PubMed ID: 21390248 [TBL] [Abstract][Full Text] [Related]
36. Leucine-rich repeat kinase 2 interacts with p21-activated kinase 6 to control neurite complexity in mammalian brain. Civiero L; Cirnaru MD; Beilina A; Rodella U; Russo I; Belluzzi E; Lobbestael E; Reyniers L; Hondhamuni G; Lewis PA; Van den Haute C; Baekelandt V; Bandopadhyay R; Bubacco L; Piccoli G; Cookson MR; Taymans JM; Greggio E J Neurochem; 2015 Dec; 135(6):1242-56. PubMed ID: 26375402 [TBL] [Abstract][Full Text] [Related]
37. Role of LRRK2 kinase dysfunction in Parkinson disease. Kumar A; Cookson MR Expert Rev Mol Med; 2011 Jun; 13():e20. PubMed ID: 21676337 [TBL] [Abstract][Full Text] [Related]
38. Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization. Sen S; Webber PJ; West AB J Biol Chem; 2009 Dec; 284(52):36346-36356. PubMed ID: 19826009 [TBL] [Abstract][Full Text] [Related]